Treatment alternatives for chronic rhinosinusitis persisting after ESS: What to do when antibiotics, steroids and surgery fail

Rhinology

Volumn 46, Issue 1, 2008, Pages 3-14

  Desrosiers, Martin Y ^a,b   Kilty, Shaun J ^a  

^a CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

Alternative medicine; Antibiotic therapy; Antifungal therapy; Biofilm therapy; Biofilms; Coagulase negative staphylococci; Endoscopic sinus surgery; Haemophilus influenza; Nasal irrigation; Pseudomonas aeruginosa; Recurrent chronic sinusitis; Staphylococcus aureus

Indexed keywords

ANTIINFECTIVE AGENT; CORTICOSTEROID; IMMUNOGLOBULIN;

ALTERNATIVE MEDICINE; CHRONIC DISEASE; ENDOSCOPY; HUMAN; PATHOPHYSIOLOGY; REOPERATION; REVIEW; SINUSITIS; TREATMENT FAILURE;

ADRENAL CORTEX HORMONES; ANTI-BACTERIAL AGENTS; CHRONIC DISEASE; COMPLEMENTARY THERAPIES; ENDOSCOPY; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; REOPERATION; SINUSITIS; TREATMENT FAILURE;

EID: 41349119873     PISSN: 03000729     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (87)

1. Gliklich RE, Metson R. The health impact of chronic sinusitis in patients seeking otolaryngologic care. Otolaryngol Head Neck Surg 1995; 113: 104-910.
2. Fokkens W, Lund V, Mullol J; European Position Paper on Rhinosinusitis and Nasal Polyps group. European position paper on rhinosinusitis and nasal polyps 2007. Rhinol Suppl.20. 2007: 1-136.
3. Stammberger H. Endoscopic endonasal surgery-concepts in treatment of recurring rhinosinusitis. Part I. Anatomic and pathophysiologic considerations. Otolaryngol Head Neck Surg 1986; 94: 143-147.
4. Meltzer EO, Hamilos DL, Hadley JA, Lanza DC, Marple BF, Nicklas RA, et al. Rhinosinusitis: Establishing definitions for clinical research and patient care. Otolaryngol Head Neck Surg 2004; 131 (6 Suppl): S1-62.
5. Durr DG, Desrosiers MY, Dassa C. Quality of life in patients with rhinosinusitis. J Otolaryngol 1999; 28: 108-111.
6. Nagi MM, Desrosiers MY. Igorithms for management of chronic rhinosinusitis. Otolaryngol Clin North Am. 2005; 38: 1137-1141.
7. Desrosiers M. Refractory chronic rhinosinusitis: pathophysiology and management of chronic rhinosinusitis persisting after endoscopic sinus surgery. Curr Allergy Asthma Rep. 2004; 4: 200-207.
8. Rosenfeld RM. Clinical practice guideline on adult sinusitis. Otolaryngol Head Neck Surg. 2007; 137: 365-77.
9. Guidance for Industry Sinusitis: Designing Clinical Development Programs of Nonantimicrobial Drugs for Treatment http://www.fda.gov/cder/guidance/ 7316dft.htm, created Nov. 21, 2006, accessed January 20, 2008.
10. Schuenemann HJ, Jaeschke R, Cook DJ., et al on behalf of the ATS Documents Development and Implementation Committee An Official ATS Statement: Grading the Quality of Evidence and Strength of Recommendations in ATS Guidelines and Recommendations Am J Respir Crit Care Med Vol 174. pp 605-614, 2006 DOI:10.1164/rccm.200602-197ST
11. Anand VK. Epidemiology and economic impact of rhinosinusitis Ann Otol Rhinol Laryngol 2004; 193(Suppl): 3-5.
12. Owings MF, Kozak LJ. Ambulatory and inpatient procedures in the United States 1996. National Center for Health Statistics. Vital Health Stat 1998; 13: 25.
13. Kennedy DW. Prognostic factors, outcomes, and staging in ethmoid sinus surgery. Laryngoscope 1992; 102 (suppl 57): 1-18.
14. Lund VJ, Holstrom M, Scadding GK. Functional endoscopic sinus surgery in the management of chronic rhinosinusitis: An objective assessment. J Laryngol Otol 1991; 105: 832-835.
15. Smith TL, Mendolia-Loffredo S, Loehrl TA, Sparapani R, Laud PW, Nattinger AB Predictive factors and outcomes in endoscopic sinus surgery for chronic rhinosinusitis. Laryngoscope. 2005; 115: 2199-2205.
16. Tewfik M, Bossé Y, Hudson, TJ, Vallée-Smejda S, Desrosiers M. Assessment of Toll-like Receptor 2 Gene Polymorphisms in Severe Chronic Rhinosinusitis J Otolaryngol. In pres.
17. Passali D, Bellussi L, Hassan HA et al. Consensus Conference on Nasal Polyposis. Acta Otorhinolaryngol Ital 2004; 24: 3-61.
18. Van Cauwenberge P, Van Hoecke H, Bachert C.Pathogenesis of chronic rhinosinusitis. Curr Allergy Asthma Rep. 2006; 6: 487-494.
19. Lavigne F, Nguyen CT, Cameron L, Hamid Q, Renzi PM.: Prognosis and prediction of response to surgery in allergic patients with chronic sinusitis. J Allergy Clin Immunol. 2000; 105: 746-751.
20. Ramanathan M, Jr., Lane AP. Innate immunity of the sinonasal cavity and its role in chronic rhinosinusitis. Otolaryngol Head Neck Surg 2007; 136: 348-356.
21. Lane AP, Truong-Tran QA, Schleimer RP. Altered expression of genes associated with innate immunity and inflammation in recalcitrant rhinosinusitis with polyps. Am J Rhinol 2006 ;20: 138-144.
22. Desrosiers M, Hussain A, Frenkiel S, Kilty S, Marsan J, Witterick I, Wright E. Intranasal corticosteroid use is associated with lower rates of bacterial recovery in chronic rhinosinusitis Otolaryngol Head Neck Surg. 2007; 136: 605-609.
23. Seiberling KA, Conley DB, Tripathi A, Grammer LC, Shuh L, Haines GK, 3rd, et al. Superantigens and chronic rhinosinusitis: detection of staphylococcal exotoxins in nasal polyps. Laryngoscope 2005; 115: 1580-1585.
24. Conley DB, Tripathi A, Seiberling KA, Suh LA, Harris KE, Paniagua MC, et al. Superantigens and chronic rhinosinusitis II: analysis of T-cell receptor V beta domains in nasal polyps. Am J Rhinol 2006; 20: 451-455.
25. Zhang N, Holtappels G, Claeys C, Huang G, van Cauwenberge P, Bachert C. Pattern of inflammation and impact of Staphylococcus aureus enterotoxins in nasal polyps from southern China. Am J Rhinol 2006; 20: 445-450.
26. Van Zele T, Claeys S, Gevaert P, Van Maele G, Holtappels G, Van Cauwenberge P, Bachert C. Differentiation of chronic sinus diseases by measurement of inflammatory mediators. Allergy. 2006; 61: 1280-1289.
27. Fakhri S, Tulic M, Christodoulopoulos P, Fukakusa M, Frenkiel S, Leung DY, Hamid QA. Microbial superantigens induce glucocorticoid receptor beta and steroid resistance in a nasal explant model. Laryngoscope. 2004; 114: 887-892.
28. Sanderson SR, Leid JG, Hunsaker DH: Bacterial biofilms on the sinus mucosa of human subjects with chronic rhinosinusitis. Laryngoscope 2006, 116: 1121-1126.
29. Plouin-Gaudon I, Clement S, Huggler E, Chaponnier C, Francois P, Lew D, et al. Intracellular residency is frequently associated with recurrent Staphylococcus aureus rhinosinusitis. Rhinology 2006; 44: 249-254.
30. Cryer J, Shipor I, Perloff JR, et al.: Evidence of bacterial biofilms in human chronic sinusitis. ORL J Otorhinolaryngol Relat Spec 2004, 66: 155-158.
31. Sanclement JA, Webster P, Thomas J, et al.: Bacterial biofilms in surgical specimens of patients with chronic rhinosinusitis. Laryngoscope 2005, 115: 578-582.
32. Psaltis AJ, Ha KR, Beule AG, et al.: Confocal scanning laser microscopy evidence of biofilms in patients with chronic rhinosinusitis. Laryngoscope 2007, 117: 1302-1306.
33. Bendouah Z, Barbeau J, Hamad W, Desrosiers M. Biofilm formation by Staphylococcus aureus and Pseudomonas aeruginosa is associated with an unfavourable evolution after surgery for chronic sinusitis and nasal polyposis. Otolaryngol - Head Neck Surg 2006; 134,:991-996.
34. Psaltis AJ, Weitzel, EK, Ha KR, Wormald PJ: Bacterial biofilms and post sinus surgical outcomes. Am J Rhinol 2008, In press.
35. Ponikau JU, Sherris DA, Kern EB, Homburger HA, Frigas E, Gaffey TA, Roberts GD The diagnosis and incidence of allergic fungal sinusitis. Mayo Clin Proc. 1999; 74: 877-884.
36. Shin SH, Ponikau JU, Sherris DA, Congdon D, Frigas E, Homburger HA, Swanson MC, Gleich GJ, Kita H. Chronic rhinosinusitis: an enhanced immune response to ubiquitous airborne fungi. J Allergy Clin Immunol. 2004; 114: 1369-1375.
37. Kim SH, Park HS, Holloway JW, Shin RD, Park CS. Association between a TGFbeta1 promoter polymorphism and rhinosinusitis in aspirin-intolerant asthmatic patients. 2007; 10: 490-495.
38. Cheng YK, Lin CD, Chang WC, Hwang GY, Tsai SW, Wan L, Tsai MH, Tsai JJ, Tsai FJ. Increased prevalence of interleukin-1 receptor antagonist gene polymorphism in patients with chronic rhinosinusitis. Arch Otolaryngol Head Neck Surg. 206; 132: 285-290.
39. Seppänen M, Suvilehto J, Lokki ML, Notkola IL, Järvinen A, Jarva H, Seppälä I, Tahkokallio O, Malmberg H, Meri S, Valtonen V. Immunoglobulins and complement factor C4 in adult rhinosinusitis. Clin Exp Immunol. 2006; 145: 219-227.
40. Al-Shemari H, Bossé Y, Hudson T, Cabaluna M, Duval M, Lemire M, et al. Influence of Leukotriene Gene Polymorphisms on Chronic Rhinosinusitis. BMC Genomics, in press
41. Wang X, Moylan B, Leopold DA, et al. Mutation in the gene responsible for cystic fibrosis and predisposition to chronic rhinosinusitis in the general population. JAMA. 2000; 284: 1814-1819.
42. Dufresne S, Desrosiers M. Contamination of post-endoscopic sinus surgery sinus cavities with Pasteurella multocida. J Otolaryngol. 2007; 36: 35-36.
43. Ramsey BW, Dorkin HL, Eisenberg JD et al. Efficacy of aerosolized tobramycin in pateints with cystic fibrosis. New Engl J Med 1993; 328: 1740-1746.
44. Kobayashi T, Baba S. Topical use of antibiotics for paranasal sinusitis. Rhinology 1992; 14 (suppl): 77-81.
45. Moss RB, King, VV. Management of sinusitis in cystic fibrosis by endoscopic sinus surgery and serial antimicrobial lavage: Reduction of reccurrence requiring surgery. Archives of Otolaryngology -Head and Neck Surgery 1995; 121: 566-572.
46. Hyo N, Takano H, Hyo Y. Particle deposition efficiency of therapeutic aerosols in the human maxillary sinus. Rhinology 1989; 27: 17-26.
47. Merkus P, Ebbens FA, Muller B, Fokkens WJ. The 'best method' of topical nasal drug delivery: comparison of seven techniques. Rhinology. 2006; 44: 102-107.
48. Olson DE, Rasgon BM, Hilsinger RL Jr. Radiographic comparison of three methods for nasal saline irrigation. Laryngoscope. 2002; 112: 1394-1398.
49. Harvey R, Hannan SA, Badia L, Scadding G. Nasal saline irrigations for the symptoms of chronic rhinosinusitis.Cochrane Database Syst Rev. 2007; 18: CD006394
50. Tomooka L, Murphy C, Davidson TM. Clinical study and literature review of nasal irrigation. Laryngoscope 2000; 110(July):1189-1193.
51. Watanabe K, Kanaizumi E et al. Effects of glucocorticosteroids on infiltrating cells and epithelial cells of nasal polyposis. Ann Otol Rhinol Laryngol 2004; 113: 465-473.
52. Schleimer RP. Glucocorticoids suppress inflammation but spare innate immune responses in airway epithelium. Proc Am Thorac Soc 2004; 1: 222-230.
53. Landsberg R, Segev Y, DeRowe A, Landau T, Khafif A, Fliss DM. Systemic corticosteroids for allergic fungal rhinosinusitis and chronic rhinosinusitis with nasal polyposis: a comparative study. Otolaryngol Head Neck Surg. 2007; 136: 252-257.
54. Desrosiers M, Hussain A, Frenkiel S, Kilty S, Marsan J, Witterick I, Wright E. Intranasal corticosteroid use is associated with lower rates of bacterial recovery in chronic rhinosinusitis Otolaryngol Head Neck Surg. 2007; 136: 605-609.
55. Lavigne F, Cameron L, Renzi, P. Intrasinus administration of topical budesonide to allergic patients with chronic rhinosinusitis following surgery. Laryngoscope. 2002 May; 112: 858-864.
56. Keith P, Nieminen J, Hollingworth K, Dolovich J. Efficacy and tolerability of fluticasone propionate nasal drops 400 microgram once daily compared with placebo for the treatment of bilateral polyposis in adults. Clin Exp Allergy. 2000; 30: 1460-1468.
57. Merkus P, Ebbens FA, Muller B, Fokkens WJ. Influence of anatomy and head position on intranasal drug deposition. Eur Arch Otorhinolaryngol. 2006; 263: 827-832
58. Aukema AA, Mulder PG, Fokkens WJ. Treatment of nasal polyposis and chronic rhinosinusitis with fluticasone propionate nasal drops reduces need for sinus surgery. J Allergy Clin Immunol. 2005; 115: 1017-1023.
59. Wright ED. Safety of Sinonasal Steroid Irrigations - Lack of Significant Adrenal Suppression J Otolaryngol. in press.
60. Vaughan WC, Carvalho G Use of nebulized antibiotics for acute infections in chronic sinusitis. Otolaryngol Head Neck Surg. 2002; 127: 558-568.
61. Desrosiers MY, Salas-Prato M. Treatment of chronic rhinosinusitis refractory to other treatments with topical antibiotic therapy delivered by means of a large-particle nebulizer: results of a controlled trial. Otolaryngol Head Neck Surg. 2001; 125: 265-269.
62. Vaughan WC, Carvalho G. Use of nebulized antibiotics for acute infections in chronic sinusitis. Otolaryngol Head Neck Surg. 2002; 127: 558-568.
63. Desrosiers, M, Bendouah, Z, Barbeau, J. Effectiveness of topical antibiotics on Staphylococcus aureus biofilm in vitro American Journal of Rhinology, Am J Rhinol. 2007; 21: 149-153.
64. Fujii T, Kadota J, Kawakami K, Iida K, Shirai R, Kaseda M, Kawamoto S, Kohno S. Long term effect of erythromycin therapy in patients with chronic Pseudomonas aeruginosa infection. Thorax. 1995; 50: 1246-1252.
65. Moriyama H, Yanagi K, Ohtori N, Fukami M Evaluation of endoscopic sinus surgery for chronic sinusitis: post-operative erythromycin therapy. Rhinology. 1995; 33: 166-170.
66. Cervin A, Kalm O, Sandkull P, Lindberg S One-year low-dose erythromycin treatment of persistent chronic sinusitis after sinus surgery: clinical outcome and effects on mucociliary parameters and nasal nitric oxide. Otolaryngol Head Neck Surg. 2002, 126: 481-489.
67. Ragab SM, Lund VJ, Scadding G. Evaluation of the medical and surgical treatment of chronic rhinosinusitis: a prospective, randomised, controlled trial.Laryngoscope. 2004; 114: 923-930.
68. Ponikau JU, Sherris DA, Weaver A, Kita H. Treatment of chronic rhinosinusitis with intranasal amphotericin B: a randomized, placebo-controlled, double-blind pilot trial. J Allergy Clin Immunol. 2005; 115: 125-131.
69. Ebbens FA, Scadding GK, Badia L, Hellings PW, Jorissen M, Mullol J, Cardesin A, Bachert C, van Zele TP, Dijkgraaf MG, Lund V, Fokkens WJ. Amphotericin B nasal lavages: not a solution for patients with chronic rhinosinusitis. J Allergy Clin Immunol. 2006; 118: 1149-5116.
70. Rains BM 3rd, Mineck CW Treatment of allergic fungal sinusitis with high-dose itraconazole. Am J Rhinol. 2003; 17: 1-8.
71. Parnes SM, Chuma AV Acute effects of antileukotrienes on sinonasal polyposis and sinusitis. Ear Nose Throat J. 2000; 79: 18-20, 24-25.
72. Parnes SM The role of leukotriene inhibitors in patients with paranasal sinus disease. Curr Opin Otolaryngol Head Neck Surg. 2003; 11: 184-191.
73. Berger W, De Chandt MT, Cairns CB. Zileuton: clinical implications of 5-Lipoxygenase inhibition in severe airway disease. Int J Clin Pract. 2007; 61: 663-766.
74. Pfaar O, Klimek L. Aspirin desensitization in aspirin intolerance: update on current standards and recent improvements. Curr Opin Allergy Clin Immunol. 2006; 6: 161-166.
75. Chee L, Graham SM, Carothers DG, Ballas ZK Immune dysfunction in refractory sinusitis in a tertiary care setting. Laryngoscope. 2001; 111: 233-235.
76. Videler WJ, Wreesmann VB, van der Meulen FW, Knegt PP, Fokkens WJ. Repetitive endoscopic sinus surgery failure: a role for radical surgery? Otolaryngol Head Neck Surg. 2006; 134: 586-591.
77. Costerton JW, Stewart PS, Greenberg EP: Bacterial biofilms: a common cause of persistent infections. Science 1999, 284: 1318-1322.
78. Costerton W, Veeh R, Shirtliff M, et al.: The application of biofilm science to the study and control of chronic bacterial infections. J Clin Invest 2003, 112: 1466-1477.
79. Desrosiers M, Bendouah Z, Barbeau J: Effectiveness of topical antibiotics on staphylococcus aureus in-vitro. Am J Rhinol 2007, 21: 149-153.
80. Desrosiers M, Myntti M, James G: Methods for removing bacterial biofilms: in vitro study using clinical chronic rhinosinusitis specimens. Am J Rhinol 2007, 21: 527-532.
81. Ha KR, Psaltis AJ, Butcher AR, et al.: In vitro activity of mupirocin on clinical isolates of staphylococcus aureus and its potential implications in chronic rhinosinusitis. Laryngoscope 2007, In press.
82. Habermann W, Zimmermann Y, Skarabis H, Kunze R, Rusch V. Reduction of acute recurrence in patients with chronic recurrent hypertrophic sinusitis by treatment with a bacterial immunostimulant (Enterococcus faecalis bacterie of human origin). Arzneimittelforschung. 2002; 52: 622-627.
83. Heintz B, Schlenter WW, Kirsten R, Nelson K. Clinical efficacy of Broncho-Vaxom in adult patients with chronic purulent sinusitisa mult-centric, placebo-controlled, double-blind study. Int J Clin Pharmacol Ther Toxicol. 1989; 27: 530-534.
84. Gevaert P, Lang-Loidolt D, Lackner A, Stammberger H, Staudinger H, Van Zele T, Holtappels G, Tavernier J, van Cauwenberge P, Bachert C. Nasal IL-5 levels determine the response to anti-IL-5 treatment in patients with nasal polyps. J Allergy Clin Immunol. 2006; 118: 1133-1141.
85. Koreck AI, Csoma Z, Bodai L. Rhinophototherapy: a new therapeutic tool for the management of allergic rhinitis. J Allergy Clin Immunol 2005; 115: 541-547.
86. Bella Z., Desrosiers M., Javer A, et al. Potential new application of intranasal phototherapy in nasal polyposis. Oral presentation at the 12th Congress of the International Rhinologic Society, 5-8 December 2007, Venice, Italy.
87. AAP SCQIM (American Academy of Pediatrics Steering Committee on Quality Improvement and Management). Policy Statement. Classifying recommendations for clinical practice guidelines. Pediatrics 2004;114:874-7.